GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Osiris Therapeutics, Inc. (OSIR) [hlAlert]

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company?s principal biologic drug candidate, Prochymal, is being evaluated in Phase III clinical trials for three indications,
including acute and steroid refractory Graft versus Host Disease (GvHD), Crohn's disease and for the repair of gastrointestinal injury resulting from radiation exposure, and is the only stem cell therapeutic granted both Orphan Drug and Fast Track status by the United States Food and Drug Administration (FDA). Its pipeline of internally developed biologic drug candidates under evaluation also includes Chondrogen for osteoarthritis in the knee. In August 2009, the Company announced the creation of a new Biosurgery Division focused on developing and marketing high-end biological products for use in surgical procedures.
.
( Total: 8 Current Stock Recommendations )
Osiris Therapeutics, Inc.   (8)
Sell 50% Buy 50%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Sell OSIR
down 30.00 %

Rating:
Buy OSIR
down 30.00 %

Rating:
Buy OSIR
up 40.94 %

Rating:
Buy OSIR
up 39.00 %
Osiris Therapeutics, Inc. (OSIR) rated Overweight by Piper Jaffray
Wednesday,  Oct 2, 2013  8:25 AM ET

Rating:
Sell OSIR
down 60.36 %

Rating:
Sell OSIR
down 60.36 %

Rating:
Sell OSIR
down 13.67 %

Rating:
Buy OSIR
up 7.97 %

Rating:
Sell OSIR
down 13.67 %

Rating:
Buy OSIR
up 7.97 %
Osiris Therapeutics, Inc. (OSIR) rated Buy by Wedbush Morgan
Thursday,  Mar 5, 2009  9:25 AM ET

Rating:
Buy OSIR
down 4.87 %

Rating:
Sell OSIR
down 13.67 %

Rating:
Sell OSIR
down 39.80 %

Rating:
Buy OSIR
up 39.00 %
Osiris Therapeutics, Inc. (OSIR) rated Buy by Piper Jaffray
Friday,  Jan 25, 2008  8:25 AM ET

Your Recent Stocks
SymbolLastChange
OSIR 5.14 down  -71.66 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy